← All companies

INNP

InnoCan Pharma Corporation

INNPF OTC Pharmaceutical Preparations EDGAR ↗

$1.62

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$1.43 – $14.26

Recent SEC filings

40 most recent

Other filings

FWP Apr 3, 2026

F-1/A Apr 3, 2026

FWP Mar 16, 2026

F-1 Mar 16, 2026

RW Feb 23, 2026

EFFECT Jan 30, 2026

CORRESP Jan 27, 2026

CORRESP Jan 27, 2026

F-1/A Jan 7, 2026

FWP Jan 6, 2026

F-1/A Jan 6, 2026

8-A12B/A Dec 22, 2025

8-A12B/A Dec 19, 2025

8-A12B/A Dec 16, 2025

FWP Dec 10, 2025

F-1/A Dec 10, 2025

DEL AM Nov 10, 2025

F-1/A Oct 22, 2025

FWP Oct 1, 2025

F-1/A Sep 30, 2025

CORRESP Sep 24, 2025

CORRESP Sep 22, 2025

CORRESP Sep 22, 2025

8-A12B Sep 22, 2025

FWP Sep 12, 2025

FWP Sep 5, 2025

F-1/A Sep 5, 2025

CORRESP Aug 4, 2025

F-1/A Aug 4, 2025

UPLOAD Jul 29, 2025

CORRESP Jul 23, 2025

F-1 Jul 23, 2025

UPLOAD Jun 27, 2025

DRS/A Jun 20, 2025

DRSLTR May 15, 2025

DRS/A May 15, 2025

UPLOAD May 14, 2025

DRSLTR May 12, 2025

DRS/A May 12, 2025

UPLOAD May 8, 2025